Veracyte, Inc. (VCYT)
33.85
-0.83
(-2.39%)
USD |
NASDAQ |
Mar 06, 16:00
33.86
+0.01
(+0.03%)
Pre-Market: 20:00
Veracyte Cash from Investing (TTM) : -9.209M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Thermo Fisher Scientific, Inc. | -4.047B |
| FONAR Corp. | -4.009M |
| Interpace Biosciences, Inc. | -0.447M |
| XWELL, Inc. | 8.51M |
| Hypha Labs, Inc. | -0.0312M |